SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®
Zusterzeel R, Curtis J, Canos D, Sanders W, Selzman K, Pina I, Spatz E, Bao H, Ponirakis A, Varosy P, Masoudi F, Strauss D. SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®. Journal Of The American College Of Cardiology 2014, 63: a719. DOI: 10.1016/s0735-1097(14)60719-1.Peer-Reviewed Original Research